These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6322282)
1. Cell surface alterations induced by the acycloguanosine (ACG) resistant and sensitive strains of herpes simplex virus type 2 (HSV-2) in the presence of ACG and tunicamycin. Gamliel H; Katz E Scan Electron Microsc; 1983; (Pt 4):2037-45. PubMed ID: 6322282 [TBL] [Abstract][Full Text] [Related]
2. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239 [TBL] [Abstract][Full Text] [Related]
3. Scanning electron microscopy of CV-1 and HeLa cells infected with herpes simplex viruses types 1 and 2. Katsumoto T; Hattori N; Kurimura T Acta Virol; 1984 Sep; 28(5):401-6. PubMed ID: 6151354 [TBL] [Abstract][Full Text] [Related]
4. Characterization of an herpes simplex virus type 2 mutant, which is resistant to acycloguanosine and causes fusion of BSC1 cells. Katz E; Margalith E Arch Virol; 1982; 74(2-3):111-23. PubMed ID: 6299232 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine). Smith KO; Kennell WL; Poirier RH; Lynd FT Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967 [TBL] [Abstract][Full Text] [Related]
6. Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples. Mah IW; Kuo BI; Wei HY; Tsai CH; Liu WT Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Feb; 30(1):51-4. PubMed ID: 10592810 [TBL] [Abstract][Full Text] [Related]
7. Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine. Harmenberg J; Wahren B; Oberg B Intervirology; 1980; 14(5-6):239-44. PubMed ID: 6265398 [TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of tunicamycin on herpes simplex virus. Katz E; Margalith E; Duksin D Antimicrob Agents Chemother; 1980 Jun; 17(6):1014-22. PubMed ID: 6250466 [TBL] [Abstract][Full Text] [Related]
9. High voltage electron microscopy of whole cells infected with herpes simplex virus type 1. Yoshida M; Uno F; Nii S J Electron Microsc (Tokyo); 1986; 35(1):47-59. PubMed ID: 3027223 [No Abstract] [Full Text] [Related]
10. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine. Kufe D; Herrick D; Crumpacker C; Schnipper L Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173 [TBL] [Abstract][Full Text] [Related]
11. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus. Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018 [TBL] [Abstract][Full Text] [Related]
12. Resistance of HSV-1 growth to aphidicolin in two aphidicolin resistant cell lines. Rappazzo G; Grillo A; Biondi O; Sammartano F; Pignatti PF Microbiologica; 1986 Jul; 9(3):381-6. PubMed ID: 3018456 [TBL] [Abstract][Full Text] [Related]
13. Glucosamine metabolism of herpes simplex virus infected cells. Inhibition of glycosylation by tunicamycin and 2-deoxy-D-glucose. Olofsson S; Lycke E Arch Virol; 1980; 65(3-4):201-9. PubMed ID: 6251782 [TBL] [Abstract][Full Text] [Related]
14. Study on the apparent resistant strains of herpes simplex virus type 1 against 9-beta-D-arabinofuranosyladenine. Yoshida T; Suzutani T; Azuma M Tohoku J Exp Med; 1988 Nov; 156(3):279-90. PubMed ID: 2855280 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus. Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436 [TBL] [Abstract][Full Text] [Related]
17. [Combined activity of meliacin and foscarnet against different strains of herpes simplex virus type 1 using a three-dimensional model]. Barquero AA; Villamil SM Rev Argent Microbiol; 1997; 29(1):32-7. PubMed ID: 9229723 [TBL] [Abstract][Full Text] [Related]
18. The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity. Carter VC; Schaffer PA; Tevethia SS J Immunol; 1981 May; 126(5):1655-60. PubMed ID: 6971309 [TBL] [Abstract][Full Text] [Related]
19. [The suppression of a herpes simplex virus reproduction with drug resistance by combination 15lys-bis-nt and phosphate of acycloguanosine with some antiherpetic drugs]. Andronova VL; Grokhovskiĭ SL; Deriabin PG; Gurskiĭ GV; Surovaia AN; Jas'ko MV; Kukhanova MK; Kochetkov SN; Skoblov IuS; Galegov GA Vopr Virusol; 2014; 59(4):37-41. PubMed ID: 25549466 [TBL] [Abstract][Full Text] [Related]
20. Adsorption and penetration of enveloped herpes simplex virus particles modified by tunicamycin or 2-deoxy-D-glucose. Svennerholm B; Olofsson S; Lundén R; Vahlne A; Lycke E J Gen Virol; 1982 Dec; 63(2):343-9. PubMed ID: 6296282 [No Abstract] [Full Text] [Related] [Next] [New Search]